Giving Anaesthetists Control
Safer Injection for Regional Anaesthesia
SAFIRA®: SAFer Injection for Regional Anaesthesia
Current Regional Anaesthesia process:
Regional anaesthesia procedures require two operators - an anaesthetist who holds an ultrasound scanner and uses this to guide the needle tip placement and a second operator to inject the anaesthetic solution at a required pressure.
It has been reported that anaesthetic solutions are often injected at high pressure.
High pressure can cause damage to nerve fascicles, with serious nerve damage occurring in up to 1% of procedures and transient nerve damage in up to 8% of cases [1,2].
A revolutionary new technology for Regional Anaesthesia:
SAFIRA® - SAFer Injection for Regional Anaesthesia - allows a single operator, an anaesthetist or anesthesiologist, to conduct the whole regional block at safer pressures.
SAFIRA® has been developed in line with international quality standards. Medovate is ISO 13485:2016 certified.
Medovate have appointed distributors for this exciting new technology.
VYGON is the appointed distributor for Europe and the UK. There are distributors providing 100% coverage in the United States of America. There are also active distributors covering Australia and New Zealand, and Israel.
Find details of all appointed distributors here.
Distributors for other countries are in the process of being appointed.
Videos about SAFIRA®:
Scroll down to find videos about the new SAFIRA® technology for regional anaesthesia.
[References: 1. Borgeat A, Blumenthal S. Nerve injury and regional anaesthesia [Internet]. Vol. 17, Current Opinion in Anaesthesiology. 2004 [cited 2020 Mar 31]. p.417–21. Available from: http://www.ncbi.nlm.nih.gov/pu... 2. Jeng CL, Torrillo TM, Rosenblatt MA. Complications of peripheral nerve blocks. Br J Anaesth [Internet]. 2010 [cited 2020 Mar 31];105(S1):97–107. Available from: https://academic.oup.com/bja/a...]
Videos about SAFIRA
Revolutionary new technology for regional anaesthesia